Right now I see AVXL trading at $9.15. Up for the day by 5.54%
But the Dow Jones Industrials are down 1.09%. The NASDAQ is down 3.04%.
Anavex isn't moving, descending, with the markets. Prospects of imminent European Medicines Agency approval of Blarcamesine for Alzheimer's continues to drive AVXL pricing.
Then, when the EMA gives formal approval, daily share price increases will be double digit percentages.
Market Data 
Markets 
AI
